Strategic Planning Services
Pharmaceutical Product Design
- New Formulations of well-established drugs with unique features allowing market differentiation and price premiums. Altus Value Added Medicines come with patent coverage exceeding market exclusivity.
- First in Man Formulations conceived, developed and provided for pre-clinical studies, GLP studies and rapid and cost-effective progress through clinical studies. We also manufacture clinical supplies for all phases of clinical testing.
- Enabling Formulations. Technology based formulations for difficult to deliver drugs including poorly soluble and insoluble drugs.
- Protective Formulations. Providing patent protection for NCE lacking patent coverage.
Drug Development Financial Strategy
Tax Incentives for pharmaceutical development
Altus Drug Development, with its unique position within Quebec, Canada can reduce the cost of your development program by leveraging tax credit advantages not seen in other countries or provinces.
Grant Incentives for your clinical and nonclinical trials
Altus can help with new grant applications to support your primary pharmacology, secondary pharmacology, and safety pharmacology testing.
Pre-Clinical Formulation Planning
IND Enabling Studies
Clinical and Commercial Manufacturing
Regulatory Planning and Submission Strategy
Regulatory intelligence and regulatory planning are essential to efficient and cost-effective product development. Regulatory planning means more than reading the guidance.
Altus provides a full range of regulatory planning and execution services from initial regulatory assessment through IND enabling study planning, dossier development and submission, clinical submission meeting planning and in-person support.
Patent Strategy for you pharmaceutical products
Products have a life-cycle and Altus’ provides, supports and executes, a patent strategy for all of them. For NCE and NME lacking patent coverage for extended market exclusivity Altus Patent Umbrella can provide protection.